Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FCX vs MRNA✓SelectedUSD · MRNAFCX vs MRNA performance historyLatest closeAs of-6.37%11/20
Stock and ETF performance explorer

FCX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+30.6%
MRNA return
-27.3%
Excess return
+57.8%
Maximum drawdown
-51.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-6.4%-2.2%-4.2%-6.2%
7D-22.4%-12.7%-9.7%-21.5%
30D-33.3%-20.7%-12.6%-32.0%
3M-35.3%+46.3%-81.6%-37.5%
6M-24.1%+305.2%-329.3%-38.8%
YTD-8.6%+561.2%-569.8%-32.4%
1Y+17.1%+772.1%-755.0%-17.4%
3Y+30.2%+147.0%-116.7%+3.2%
All+30.6%-27.3%+57.8%+8.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling